Access cutting-edge breast cancer treatment through this clinical trial at a research site in Corona. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Corona at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This study will evaluate the efficacy and safety of inavolisib in combination with Phesgo (pertuzumab, trastuzumab, and rHuPH20 injection for subcutaneous use) compared with placebo in combination with Phesgo, as maintenance therapy, after induction therapy in participants with previously untreated HER2-positive advanced breast cancer (ABC).
Sponsor: Hoffmann-La Roche
Check if you qualify for this breast cancer clinical trial in Corona, CA
If you're searching for breast cancer treatment options in Corona, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Corona research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.